Inge Osman advises domestic and multinational clients on their highest-stakes intellectual property litigation, including before federal district and appellate courts, as well as the Patent Trial and Appeal Board (PTAB).

Combining sophisticated technical knowledge and significant trial experience, Ms. Osman helps clients achieve their desired outcomes in complex patent litigation. She has successfully represented clients in matters involving a range of technologies, including pharmaceuticals, biotechnology, antibodies, medical devices, semiconductors, liquid crystal display technologies, biometric scanning devices, information technology, and call processing systems.

Ms. Osman draws on her scientific training and prior experience clerking for the Federal Circuit to identify the most successful arguments in patent disputes. She received undergraduate degrees in Electrical and Computer Engineering and Biomedical Engineering from Duke University. Ms. Osman previously clerked for Judge Kimberly A. Moore of the US Court of Appeals for the Federal Circuit.

Ms. Osman’s broad-based trial work includes arguing in court and before the PTAB, deposing key fact and expert witnesses, and managing fact and expert discovery. She brings particular experience litigating patent matters in federal courts and in post-grant proceedings before the PTAB. Ms. Osman also regularly coordinates parallel proceedings — including matters brought to both a district court and the PTAB, as well as disputes spanning multiple jurisdictions.

She is a member of the PTAB Bar Association’s Appellate and Diversity Committees and a member of the Federal Circuit Bar Association. 

Ms. Osman’s representative experience includes:

  • J&J Surgical Vision v. Alcon: Represented J&J in a series of inter partes review (IPR) proceedings before the PTAB and obtained final written decisions confirming the validity of almost all (219 of 234) challenged claims across twelve patents.
  • InductEV (formerly known as Momentum Dynamics): Represented InductEV in a series of proceedings dealing with wireless charging technology at the PTAB. The Latham team convinced the PTAB to take the rare move to reverse an initial decision denying IPR. Upon review, the PTAB found all challenged claims unpatentable. 
  • First Quality v. Irving. Represented Irving in a jury trial victory in the United States District Court for the District of Delaware. After a week-long trial, the jury returned a verdict of non-infringement and invalidity in favor of Irving.
  • AbbVie. Represented AbbVie in multiple litigations and IPR proceedings involving Humira®, the first human monoclonal antibody drug, including litigation with biosimilar challengers.
  • Latch v. LET Investor Group. Represented Latch in a multi-jurisdictional dispute involving trade secret misappropriation, breach of contract, and civil RICO claims. Each of the Virginia state claims were dismissed and the remaining litigation was favorably resolved.
  • Intellectual Ventures v. Symantec. Represented Symantec and Veritas in a lawsuit brought by IV alleging infringement of three patents. By the completion of summary judgment briefing, only two claims of one patent remained. Successfully obtained summary judgment of both non-infringement and invalidity based on 35 U.S.C. § 101.
  • Samsung Elecs. Co. v. NVIDIA Corp. Represented defendant NVIDIA in an eight-patent infringement suit brought by Samsung relating to mobile phones and tablet computers that contain graphics processing units. Samsung eventually dropped nearly all its patents. By the time of trial, only three patents remained. The judge declared a mistrial as to two patents, and the jury found the remaining patent not infringed.
  • Certain Liquid Crystal Display Devices, Inv. No. 337-TA-749: Represented defendant AU Optronics in a multiple-patent case filed by Thomson Licensing. After a one-week trial, the ALJ issued an initial determination, finding that AU Optronics did not infringe any of Thomson’s patents, and invalidating most of the asserted claims.
  • Mallinckrodt Hosp. Prods. Inc. v. Praxair Inc. Represented defendant Mallinckrodt against an ANDA challenge to ten patents covering its successful INOmax drug product and DSIR medical device, including successfully defending multiple proceedings before the Patent Office.
  • Bonutti Skeletal Innovations (Acacia) v. ConMed. Represented defendant ConMed in a patent infringement case involving nine patents and ten accused products related to medical devices in the Middle District of Florida, successfully running the table on the claim construction issues on all nine patents to obtain a favorable settlement.
  • Ronald A. Katz Technology Licensing, L.P. v. Comcast Corporation, et al. Represented defendant GEICO in a patent litigation involving multiple patents related to call center processing. The case settled on favorable terms after it was remanded form the MDL court to the trial court.
  • Lugus IP v. Volvo Car Corporation. Represented Volvo in a patent infringement case in the Eastern District of Virginia related to child safety seats, successfully transferring the case to the District of New Jersey, winning summary judgment of non-infringement for Volvo and winning an award of nearly US$1 million in attorney fees.
  • Certain Biometric Scanning Devices, Inv. No. 337-TA-720. Represented complainant Cross Match in an investigation involving four patents related to biometric scanning devices. The Administrative Law Judge found Cross Match’s patents valid and infringed, and the finding of a violation was upheld by the Commission.

Bar Qualification

  • District of Columbia
  • US Patent and Trademark Office
  • Virginia


  • JD, Harvard Law School, 2010
  • BSE in Electrical and Biomedical Engineering, Duke University, 2005
    magna cum laude
Skyscraper view, San Francisco, USA
March 14, 2023 Recognition

Litigator of the Week Runners-Up and Shout Outs

Two Latham teams were recognized for knocking out a securities class action against our client Skillz Inc., and for a rare win at the PTAB for our client InductEV.